Olympus, Leica ink digital pathology deal

Lisa Fratt | | Health Imaging | Practice Management
Olympus America and Leica Microsystems have signed a nonexclusive worldwide licensing agreement providing Leica access to Olympus’ portfolio of digital pathology and virtual microscopy patents.

The patents included in the licensing deal cover methods and equipment for creating, storing and delivering virtual microscopy slides, which enable individuals to view and share high-resolution virtual microscopy images over the Internet.

Center Valley, Penn.-based Olympus and Weztlar, Germany-based Leica are not making specific terms and conditions of the agreement public.

 

Lisa Fratt

Related Content

New protocol addresses contrast allergies in patients with suspected stroke
Do large language models help or hinder workflows related to radiology reports?
Hospital creates 'virtual reality technologist' role to support patients during interventional procedures
Telehealth visits not to blame for uptick in imaging orders, study shows
Up to half of medical organizations either already using or preparing to implement AI
Warning: Sidelined reactor could trigger medical isotope shortage

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.